Metoclopramide Tablets — Class II drug recall D-0075-2027
Ongoing recall by Safecor Health, LLC, reported 2026-11-04, distributed nationwide. Manufacturer is recalling batches due to co-mingled tablet.
| Recall number | D-0075-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Safecor Health, LLC, Rockford, IL, United States |
| Recall initiated | 2026-10-06 |
| Classified | 2026-10-23 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| NDC | 51079-0886, 51079-0886-01, 51079-0886-20, 51079-0888, 51079-0888-01, 51079-0888-20 |
| Lot numbers | 3116509 |
| Expiration dates | 2027-07-31 |
Product
Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20.
Reason for recall
Manufacturer is recalling batches due to co-mingled tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0075-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.